Science ❯ Biotechnology

Clinical Research

Antibody Development Diagnostic Methods Therapeutic Areas Drug Development

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet

The purchase marks Pfizer’s pivot toward cardiometabolic drugs following setbacks in its oral GLP‑1 program.

AbbVie Extends Rinvoq U.S. Exclusivity to 2037 as AI Biotechs Move From Models to Medicines